15—17 March 2016
St. Catharine’s College, Cambridge, UK
The aim of this Biochemical Society focused meeting is to explore the mechanisms of BMP signal transduction and regulation of signalling, and discuss how genetic and epigenetic alterations result in aberrant signalling and how this leads to cancer. The BMP signalling pathway is a key therapeutic target and we will consider how to manipulate the pathway with small molecules or biologics. This conference will bring together researchers from academe and industry, and will be a great opportunity for those working on BMP signalling, cancer, stem cells, structural biology and drug discovery to share data and interact in a vibrant, but informal environment.
- Caroline Hill (The Francis Crick Institute, United Kingdom)
- Alex Bullock (University of Oxford, United Kingdom)
- Gareth Inman (University of Dundee, United Kingdom)
- Mechanisms of BMP signalling
- Deregulation of BMP signalling in cancer and therapeutic approaches
- Genetic and epigenetic alterations in BMP pathway components
- BMP signalling in disease
Details of the event and a list of speakers can be found here.
There will be opportunities for abstracts to be elevated to short oral talks, particularly from early-career scientists.